Rapid diagnostic test for Strongyloides infection
Official title: Rapid Diagnostic Immunoassay for Strongyloidiasis
Funded at Kephera Diagnostics, LLC · NIH-11256317 · Data updated 2026-11-12
A quick, easy-to-use test is being developed to detect Strongyloides infections, helping people who may have returned from at-risk areas or who are immunocompromised.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kephera Diagnostics, LLC NIH-funded |
| Lab location | 1 site (Framingham, UNITED STATES) |
| Project start | August 24, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $303,250 |
| NIH project number | 1R43AI186917-01A1 |
| Project ID | NIH-11256317 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with suspected strongyloidiasis or those at risk due to travel, residence in endemic areas, or immunosuppression.
✕Less likely to help
People without strongyloidiasis or without exposure risk are unlikely to benefit.
What this research studies
This project aims to create a rapid immunoassay that can diagnose strongyloidiasis more accurately than current stool tests. It focuses on delivering a practical test that healthcare providers can use in clinical settings, including areas with limited lab capacity. The work involves validating the test performance and ensuring it works well in diverse patient samples, particularly among people who may have weakened immune systems.
Why it matters
Potential benefit: If successful, the test could lead to faster, more reliable diagnosis and timely treatment for people with Strongyloides infection.
How similar studies have gone: Previous diagnostics for strongyloidiasis have limitations, so this represents a meaningful improvement rather than a proven approach.
Where this research is happening
-
Kephera Diagnostics, LLC
Framingham, United States Active
Researchers
- Principal investigator: Levin, Andrew E. — Kephera Diagnostics, LLC
- Study coordinator: Levin, Andrew E.
Related research
Other NIH-funded projects on the same topics.
-
Peptide-based Diagnostic Test for Sarcoidosis
A new test using peptide-based ELISA is being developed to diagnose sarcoidosis, potentially reducing the need for invasive lung biopsies.
-
Rapid bedside test for neurocysticercosis in adults with seizures
A quick clinic test to detect brain tapeworm infection (neurocysticercosis) in adults who present with seizures.
-
Finding new ways to diagnose neglected tropical diseases.
This study is looking for new ways to quickly and accurately diagnose neglected tropical diseases caused by a parasite called T. cruzi, so that patients can get the right treatment sooner.
-
Creating a blood test for herpes simplex viruses 1 and 2.
This study is working on a new blood test that can help find out if someone has been infected with the herpes virus, so that people can get better treatment and support for their condition.
-
Single-step, more accurate blood test for Lyme disease
This project is creating a single-step blood test that is easier to use and less likely to give false positives so people get faster, clearer Lyme diagnoses.
-
Biomarker test to confirm cure from Chagas disease
A blood-based biomarker test to tell people treated for Chagas disease whether the infection is cured.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.